Home › Companies › AADI BIOSCIENCE INC. › 2023-2024
At AADI BIOSCIENCE INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 90 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 393 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the named executive officers identified… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AADI BIOSCIENCE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AADI BIOSCIENCE INC.’s Form 8-K, filed June 12, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 11, 2024: 4 items on AADI BIOSCIENCE INC.’s Form 8-K, filed June 12, 2024: 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AADI BIOSCIENCE INC. in the interactive database Compare manager voting policies
These tallies are AADI BIOSCIENCE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Caley Castelein, M.D. | 9,946,929 | -- | -- | 1,906,524 | 3,251,160 | 84% | Not verified | — |
| Elect Director: Neil Desai, Ph.D. | 8,171,610 | -- | -- | 3,681,843 | 3,251,160 | 69% | Not verified | — |
| 2. To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the Proxy Statement | 8,971,541 | 2,599,458 | 282,454 | -- | 3,251,160 | 78% | Not verified | — |
| 3. Ratification of the appointment of BDO USA LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 13,464,651 | 635,298 | 1,004,664 | -- | -- | 95% | Not verified | — |
Source: AADI BIOSCIENCE INC., Form 8-K, filed with the SEC on June 12, 2024 — read the filing on EDGAR.
Each item below shows how the 90 asset managers that disclosed a AADI BIOSCIENCE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect two Class I directors to serve on the Company's board of directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier resignation, death or removal: Caley Castelein, M.D.
AADI BIOSCIENCE INC.’s own tally for this item (“Elect Director: Caley Castelein, M.D.”): 9,946,929 for, 1,906,524 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 1,816,113 for, 53,741 withheld, 6,365 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 843,151 | 0 | 0 | 0 | For |
| BlackRock | 480,324 | 0 | 0 | 0 | For |
| Fidelity | 361,799 | 0 | 0 | 0 | For |
| Charles Schwab | 37,075 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 28,957 | 0 | 0 | 0 | For |
| Equitable | 19,237 | 0 | 0 | 8,560 | Mixed |
| TIAA | 20,913 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 15,604 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 7,993 | Withhold |
| T. Rowe Price | 7,681 | 0 | 0 | 0 | For |
| Pacific Life | 7,085 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,636 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 5,917 | 0 | Abstain |
| State Street | 0 | 0 | 0 | 4,822 | Withhold |
| Nationwide | 0 | 0 | 0 | 4,063 | Withhold |
| SEI | 2,900 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 2,634 | Withhold |
| DWS | 0 | 0 | 0 | 2,599 | Withhold |
| Victory Capital | 0 | 0 | 0 | 2,281 | Withhold |
| Principal | 0 | 0 | 0 | 2,258 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 1,109 | Withhold |
| Calvert | 0 | 0 | 0 | 1,086 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 500 | Withhold |
| John Hancock | 0 | 0 | 448 | 0 | Abstain |
| Morgan Stanley | 354 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
69% Majority: yes · of votes cast
Description as filed by funds: To elect two Class I directors to serve on the Company's board of directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier resignation, death or removal: Neil Desai, Ph.D.
AADI BIOSCIENCE INC.’s own tally for this item (“Elect Director: Neil Desai, Ph.D.”): 8,171,610 for, 3,681,843 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 1,825,782 for, 44,072 withheld, 6,365 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 843,151 | 0 | 0 | 0 | For |
| BlackRock | 480,324 | 0 | 0 | 0 | For |
| Fidelity | 361,799 | 0 | 0 | 0 | For |
| Charles Schwab | 37,075 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 28,957 | 0 | 0 | 0 | For |
| Equitable | 27,797 | 0 | 0 | 0 | For |
| TIAA | 20,913 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 15,604 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 7,993 | Withhold |
| T. Rowe Price | 7,681 | 0 | 0 | 0 | For |
| Pacific Life | 7,085 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,636 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 5,917 | 0 | Abstain |
| State Street | 0 | 0 | 0 | 4,822 | Withhold |
| Nationwide | 0 | 0 | 0 | 4,063 | Withhold |
| SEI | 2,900 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 2,634 | Withhold |
| DWS | 0 | 0 | 0 | 2,599 | Withhold |
| Victory Capital | 0 | 0 | 0 | 2,281 | Withhold |
| Principal | 0 | 0 | 0 | 2,258 | Withhold |
| Columbia Threadneedle | 1,109 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 1,086 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 500 | Withhold |
| John Hancock | 0 | 0 | 448 | 0 | Abstain |
| Morgan Stanley | 354 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.
AADI BIOSCIENCE INC.’s own tally for this item (“2. To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the Proxy Statement”): 8,971,541 for, 2,599,458 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 843,151 | 0 | 0 | 0 | For |
| BlackRock | 480,324 | 0 | 0 | 0 | For |
| Fidelity | 361,799 | 0 | 0 | 0 | For |
| Charles Schwab | 37,075 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 28,957 | 0 | 0 | 0 | For |
| Equitable | 27,797 | 0 | 0 | 0 | For |
| TIAA | 20,913 | 0 | 0 | 0 | For |
| Lincoln Financial | 13,900 | 1,704 | 0 | 0 | Mixed |
| AIG/SunAmerica | 7,993 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,681 | 0 | 0 | 0 | For |
| Pacific Life | 7,085 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,636 | 0 | 0 | 0 | For |
| Jackson National | 0 | 5,917 | 0 | 0 | Against |
| State Street | 4,822 | 0 | 0 | 0 | For |
| Nationwide | 4,063 | 0 | 0 | 0 | For |
| SEI | 2,900 | 0 | 0 | 0 | For |
| ProShares | 2,634 | 0 | 0 | 0 | For |
| DWS | 2,599 | 0 | 0 | 0 | For |
| Victory Capital | 2,281 | 0 | 0 | 0 | For |
| Principal | 2,258 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,109 | 0 | 0 | 0 | For |
| Calvert | 0 | 1,086 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 500 | 0 | 0 | 0 | For |
| John Hancock | 448 | 0 | 0 | 0 | For |
| Morgan Stanley | 354 | 0 | 0 | 0 | For |
Fund voting reports, all 28 managers: 1,867,511 for, 8,708 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 622,350 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 509,572 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 388,331 | 0 | 0 | 0 | For |
| State Street | 275,147 | 77 | 0 | 0 | For |
| BlackRock | 245,035 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 200,000 | 0 | 0 | 0 | For |
| Renaissance | 179,396 | 0 | 0 | 0 | For |
| Citadel | 163,172 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 162,021 | 0 | 0 | 0 | For |
| STRS OHIO | 155,500 | 0 | 0 | 0 | For |
| Northern Trust | 132,612 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 86,715 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 65,681 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 56,747 | 0 | 0 | 0 | For |
| Charles Schwab | 37,075 | 0 | 0 | 0 | For |
| SEI | 33,538 | 0 | 0 | 0 | For |
| DE Shaw | 31,345 | 0 | 0 | 0 | For |
| Dimensional | 0 | 21,105 | 0 | 0 | Against |
| Nuveen | 20,913 | 0 | 0 | 0 | For |
| Two Sigma | 17,604 | 0 | 0 | 0 | For |
| Vanguard | 12,895 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 12,022 | 0 | 0 | 0 | For |
| Prudential/PGIM | 11,055 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 10,731 | 0 | 0 | 0 | For |
| T. Rowe Price | 10,692 | 0 | 0 | 0 | For |
Institutional-manager reports, all 71 managers: 3,529,101 for, 32,137 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of BDO USA LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
AADI BIOSCIENCE INC.’s own tally for this item (“3. Ratification of the appointment of BDO USA LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 13,464,651 for, 635,298 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 28 asset managers below reported 1,876,219 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 843,151 | 0 | 0 | 0 | For |
| BlackRock | 480,324 | 0 | 0 | 0 | For |
| Fidelity | 361,799 | 0 | 0 | 0 | For |
| Charles Schwab | 37,075 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 28,957 | 0 | 0 | 0 | For |
| Equitable | 27,797 | 0 | 0 | 0 | For |
| TIAA | 20,913 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,604 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 7,993 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,681 | 0 | 0 | 0 | For |
| Pacific Life | 7,085 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,636 | 0 | 0 | 0 | For |
| Jackson National | 5,917 | 0 | 0 | 0 | For |
| State Street | 4,822 | 0 | 0 | 0 | For |
| Nationwide | 4,063 | 0 | 0 | 0 | For |
| SEI | 2,900 | 0 | 0 | 0 | For |
| ProShares | 2,634 | 0 | 0 | 0 | For |
| DWS | 2,599 | 0 | 0 | 0 | For |
| Victory Capital | 2,281 | 0 | 0 | 0 | For |
| Principal | 2,258 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,109 | 0 | 0 | 0 | For |
| Calvert | 1,086 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 500 | 0 | 0 | 0 | For |
| John Hancock | 448 | 0 | 0 | 0 | For |
| Morgan Stanley | 354 | 0 | 0 | 0 | For |
Showing the 25 largest of 28 asset managers. All 28 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 47,109,293 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 1.79% |
| 2 | BlackRock | 1.02% |
| 3 | Fidelity | 0.77% |
| 4 | Charles Schwab | 0.08% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.06% |
| 6 | Equitable | 0.06% |
| 7 | TIAA | 0.04% |
| 8 | Lincoln Financial | 0.03% |
| 9 | AIG/SunAmerica | 0.02% |
| 10 | T. Rowe Price | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Avoro Capital Advisors LLC | 1.32% |
| 2 | Vivo Capital, LLC | 1.08% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.82% |
| 4 | State Street | 0.58% |
| 5 | BlackRock | 0.52% |
| 6 | 683 Capital Management, LLC | 0.42% |
| 7 | Renaissance | 0.38% |
| 8 | Citadel | 0.35% |
| 9 | Corient Private Wealth LLC | 0.34% |
| 10 | STRS OHIO | 0.33% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BEHZAD AGHAZADEH | 25.29% | 13D |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10.04% | 13G |
| OrbiMed Advisors LLC | 8.84% | 13G |
| Fan Yu | 6.19% | 13G |
| Leonard Braden Michael | 5.17% | 13D |
| QVT Financial LP | 4.91% | 13G |
| Neil Desai | 4.82% | 13D |
| ACUTA CAPITAL PARTNERS, LLC | 3.93% | 13D |
| Vanguard Group | 2.85% | 13F |
| Renaissance Technologies | 1.15% | 13F |
Percentages above are of 47,109,293 shares outstanding, as reported by AADI BIOSCIENCE INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AADI BIOSCIENCE INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
AADI BIOSCIENCE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “AADI BIOSCIENCE (WHWK) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/aadi-bioscience-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.